Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

作者：Chi Zhang, Zhao Wu, Jiawen Li, Hong Zhao, Gui-Qiang Wang · 发表于：International Journal of Antimicrobial Agents · 年份：2020 · DOI：10.1016/j.ijantimicag.2020.105954 · 被引用次数：1837 · 研究领域：Long-Term Effects of COVID-19、COVID-19 Clinical Research Studies、Inflammasome and immune disorders